Sonnet BioTherapeutics (NASDAQ:SONN)公布2024财年每股季度亏损$(11.35)。以上内容来自Benzinga Earnings专栏,原文如下:Sonnet BioTherapeutics (NASDAQ:SONN) reported quarterly losses of $(11.35) per share.
精彩评论